FDA Prohibits Long-Approved Red Dye from Use

FDA Prohibits Long-Approved Red Dye from Use

In a significant move towards stricter regulation of synthetic dyes in consumable products, the U.S. Food and Drug Administration (FDA) has announced a ban on Red 3 (FD&C Red No. 3, E127), a commonly used synthetic food coloring, due to health concerns, including its link to cancer in animal studies.

This ban, set to take effect for food and dietary supplements by January 15, 2027, and for pharmaceuticals by January 18, 2028, reflects a move towards more cautious regulation of synthetic dyes. Food manufacturers are required to remove Red 3 from their products by January 2027.

Red 3, also known as erythrosine or E127, is a synthetic dye commonly found in food, cosmetics, and pharmaceutical products. The FDA's approval process for Red 3 in 1969 primarily relied on data submitted by manufacturers rather than conducting its own independent studies.

Exposure to Red 3 may promote the formation of thyroid tumors in rats and pigs. Rats exhibit a significantly heightened sensitivity to thyroid perturbations, with serum TSH levels in rats being approximately 6- to 60-fold higher than those typically found in humans.

The FDA's decision to ban Red 3 is based on substantial evidence of its carcinogenic potential, as well as the Delaney Clause of the Federal Food, Drug, and Cosmetic Act, which prohibits any food or color additive found to induce cancer in humans or animals.

Some companies that use or manufacture Red 3 include Bimbo Bakeries, Conagra Brands, Del Monte, Ferrara Candy Company, General Mills, Keurig Dr Pepper, Kellanova, Ferrara Candy Company, Krispy Kreme, Mondelez International, PEZ Candy, Inc., Tootsie Roll Industries, Ferro Corporation, Daiichi Sankyo Company, BASF, Sensient Technologies Corporation, and American Colors.

These companies have publicly stated their plans to reformulate products containing Red 3 in response to the FDA's ban. Independent Research Organizations could conduct studies for product approvals, ensuring unbiased evaluations. Transparency measures would need to be implemented to prevent undue influence.

The certification fee for Red 3 is $0.45 per pound. The fee was increased from $0.35 per pound as of December 9, 2024. It's important to note that these figures are speculative and actual fees could vary significantly based on real production levels and any changes in regulatory fees over time.

Public accountability mechanisms, such as allowing public comments and peer reviews on study findings, could further reduce the risk of bias and ensure that consumer interests are prioritized. A regulatory oversight committee could be established to review the findings from these independent studies.

The total fees for each manufacturer over the last 35 years, assuming each company produces approximately 1,000 pounds of Red 3 annually, could be $15,750. To estimate the number of petitions BASF might have submitted regarding Red 3 over the past 35 years, it's reasonable to estimate around 7 to 10 petitions, depending on product development and regulatory requirements.

Sensient Technologies, BASF, and Ferro Corporation have been involved in the production of colors and dyes for many decades, likely including Red 3. The levels of T3 and T4, along with TSH, can provide insights into thyroid function but cannot definitively determine the safety of Red 3 in humans.

Red 3 disrupts thyroid hormone regulation by inhibiting iodine absorption and altering hormone metabolism. Companies can classify certain substances as "Generally Recognized as Safe" (GRAS) without FDA approval, but this does not guarantee FDA agreement if questioned.

The ban on Red 3 is a significant step towards ensuring the safety of consumable products in the United States. Food manufacturers are currently in the process of reformulating products to comply with the ban, and the FDA will continue to monitor the situation closely to ensure full compliance.

1. The ban on Red 3, due to its potential carcinogenic effects, is a significant move in the realm of policy-and-legislation and health-and-wellness, setting a precedent for stricter regulation of synthetic dyes in consumable products.
2. The decision to prohibit Red 3 is based on substantial evidence from both animal studies and the Delaney Clause, reflecting a more cautious approach towards science and war-and-conflicts related to medical-conditions.
3. Companies such as Bimbo Bakeries, Krispy Kreme, and Mondelez International, which have used Red 3 in their products, are responding to the FDA's ban by reformulating their products, indicative of a shift in politics and general-news concerning consumer safety.
4. To ensure unbiased evaluations and uphold transparency, independent Research Organizations could be leveraged in the approval process for new dyes, minimizing the possibility of undue influence and addressing overall policy-and-legislation concerns.

Read also: